NCT04320082

Brief Summary

With this trial we aim to characterize the intraoperative signatures of the Direct-Current-Electroencephalogram (DC-EEG) of elderly patients developing a PostOperative Delirium (POD) compared to patients who do not develop a POD. We hereby intend to gain a better understanding of the electrical potential at the blood-brain-barrier (measured with DC-EEG) during general anaesthesia. Second, we want to study the effect of age on the DC-EEG by comparing a younger (18-30y) to an elderly cohort (\>70). Third, we aim to couple the DC-EEG signatures to blood sample analysis in order to understand the relationship between metabolic, inflammatory and vascular reaction with the intraoperative DC-EEG.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

August 10, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2021

Completed
Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

1.3 years

First QC Date

March 23, 2020

Last Update Submit

May 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • 1. DC-Shift (µV/sec) in the perioperative DC-EEG.

    Full-brain DC-EEG with 21 electrodes placed preoperatively following the 10/20-System and recording until one hour after regain of consciousness.

    From the beginning of general anaesthesia to one hour after regain of consciousness

Secondary Outcomes (9)

  • Incidence of Postoperative Delirium

    Patients will be follow until hospital discharge, or maximal until postoperative day 5

  • Additional perioperative DC-EEG signatures: morphology, polarity (positive/negative), amplitude (µV)

    From the beginning of general anaesthesia to one hour after regain of consciousness

  • DC-EEG signatures in young (18-30) vs. elderly (>70) patients

    From the beginning of general anaesthesia to one hour after regain of consciousness

  • Analysis of pre-, intra- and postoperative blood parameters

    : From shortly before the beginning of general anaesthesia to maximum one hour after arrival in the recovery room

  • Peri-operative, full-brain overall EEG band power

    Up to the end of stay in the recovery room

  • +4 more secondary outcomes

Study Arms (2)

Elderly cohort

Patients \>70 undergoing elective orthopaedic or trauma surgery under general anaesthesia.

Young cohort

Patients between 18 and 30 undergoing elective orthopaedic or trauma surgery under general anaesthesia.

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Elderly Cohort: Patients \>70 undergoing elective orthopaedic or trauma surgery under general anaesthesia. Young cohort: Patients between 18 and 30 undergoing elective orthopaedic or trauma surgery under general anaesthesia.

You may qualify if:

  • Patients aged \>70 years OR between 18 and 30
  • Planned operation time \>1 hour
  • Expected hospital treatment period of 5 days,
  • Anesthesia induction, anesthesia maintenance with either Propofol or an inhalative anesthetic agent as Sevoflurane or Desflurane,
  • The ability to give informed consent

You may not qualify if:

  • Age under 18 or between 31 and 69
  • Patients with a history of neurological or psychiatric disorders
  • Planned neurosurgery
  • Current medication of tranquilizers / antidepressants
  • Isolation of patients with multi-resistant Bacteria
  • Inability of the patients to speak and/or read German
  • Intraoperative use of ketamine, N²O, Etomidate or Dexmedetomidine
  • Participation in a prospective interventional trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin

Berlin, 13353, Germany

Location

MeSH Terms

Conditions

Delirium

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Claudia Spies, MD, Prof.

    Charite University, Berlin, Germany

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Ansthesiology and Operative Intensive Care Medicine, Charité - Universitätsmedizin Berlin

Study Record Dates

First Submitted

March 23, 2020

First Posted

March 24, 2020

Study Start

August 10, 2020

Primary Completion

November 11, 2021

Study Completion

November 11, 2021

Last Updated

May 7, 2025

Record last verified: 2025-05

Locations